跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
埃美丁 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Emedastine Difumarate Eye Drops
Approved
化学药品
Emedastine Difumarate Eye Drops
Future Health Pharma GmbH
🇨🇳 National Medical Products Administration
Approval Date
Oct 30, 2019
Approval ID
7MazXbFMp6u
Company
Future Health Pharma GmbH
Type
化学药品
Approval Details
Approval Id
7MazXbFMp6u
Approval Number
H20181192
Generic Name
富马酸依美斯汀滴眼液
Generic Name En
Emedastine Difumarate Eye Drops
Trade Name
埃美丁
Brand Name
埃美丁
Drug Type
化学药品
Dosage Form
滴眼剂
Strength
5ml:2.5mg(0.05%,以依美斯汀计)
Reg Date
2019-10-30
Expired Date
2024-10-29
Company Name
Future Health Pharma GmbH
Company Address
Guyer-Zeller-Strasse 10, 8620 Wetzikon, Switzerland
Production Company Name
Alcon - Couvreur
Production Company Address
Rijksweg 14, B-2870, Puurs, Belgium
Company Detail Path
/organization/future-health-pharma-gmbh
Production Company Detail Path
/organization/alcon-couvreur
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 30, 2019
Approval ID
7MazXbFMp6u
Type
化学药品
Back to NMPA Approvals